OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease
Julia Kraemmer, Kara Smith, Daniel Weintraub, et al.
Journal of Neurology Neurosurgery & Psychiatry (2016) Vol. 87, Iss. 10, pp. 1106-1111
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Valerie Voon, T. Celeste Napier, Michael J. Frank, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 3, pp. 238-250
Open Access | Times Cited: 321

Risk factors for non-motor symptoms in Parkinson's disease
Johan Marinus, Kangdi Zhu, Connie Marras, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 6, pp. 559-568
Open Access | Times Cited: 279

Impulse Control and Related Disorders in Parkinson's Disease
Daniel Weintraub, Daniel O. Claassen
International review of neurobiology (2017), pp. 679-717
Closed Access | Times Cited: 242

Longitudinal analysis of impulse control disorders in Parkinson disease
Jean‐Christophe Corvol, Fanny Artaud, Florence Cormier‐Dequaire, et al.
Neurology (2018) Vol. 91, Iss. 3
Open Access | Times Cited: 213

The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 155

The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 151

The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130

Dopamine Agonists and Impulse Control Disorders: A Complex Association
Marie Grall‐Bronnec, Caroline Victorri‐Vigneau, Yann Donnio, et al.
Drug Safety (2017) Vol. 41, Iss. 1, pp. 19-75
Open Access | Times Cited: 120

Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review
Emilia Gatto, Victoria Aldinio
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 96

Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 23

Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, et al.
Ageing Research Reviews (2019) Vol. 57, pp. 100994-100994
Open Access | Times Cited: 73

Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease
Hana You, Louise‐Laure Mariani, Graziella Mangone, et al.
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 111-135
Closed Access | Times Cited: 70

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease
Robert S. Eisinger, Adolfo Ramirez‐Zamora, Samuel Carbunaru, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 54

Genetic prediction of impulse control disorders in Parkinson's disease
Daniel Weintraub, Marijan Posavi, Pierre Fontanillas, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 7, pp. 936-949
Open Access | Times Cited: 28

Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease
Alessandro Tessitore, Rosa De Micco, Alfonso Giordano, et al.
Movement Disorders (2017) Vol. 32, Iss. 12, pp. 1710-1719
Closed Access | Times Cited: 60

Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review
Matthieu Béreau, Vanessa Fleury, Walid Bouthour, et al.
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 653-663
Closed Access | Times Cited: 58

Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study
Aleksander H. Erga, Guido Alves, Jan Petter Larsen, et al.
Journal of Parkinson s Disease (2016) Vol. 7, Iss. 1, pp. 183-191
Open Access | Times Cited: 50

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease
Juan Marín‐Lahoz, Frederic Sampedro, Saül Martínez‐Horta, et al.
Annals of Neurology (2019) Vol. 86, Iss. 5, pp. 762-769
Closed Access | Times Cited: 46

The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease
T. Celeste Napier, Alana Kirby, Amanda L. Persons
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 102, pp. 109942-109942
Closed Access | Times Cited: 42

Spectrum of impulse control behaviours in Parkinson’s disease: pathophysiology and management
Mark J. Kelly, Fahd Baig, Joshua Shulman, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 7, pp. 703-711
Open Access | Times Cited: 42

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies
Junfang Zhang, Xixi Wang, Ya Feng, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 35

Neuropsychiatric Manifestations in Parkinson Disease
Daniel Weintraub, Julia Gallagher, Matthew Stern
Cambridge University Press eBooks (2025), pp. 155-165
Closed Access

Impulse control disorders in Parkinson’s disease: What’s new?
Ana Marqués, Simon J.G. Lewis
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access

Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?
Leonardo Rigon, Carmelo Fogliano, К. Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access

Page 1 - Next Page

Scroll to top